Biotech

All Articles

Ideaya bags possibility on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is actually betting $400 thousand in biobucks that a bispecific antibody-drug co...

Takeda takes $140M reduction on stopped working epilepsy medicine, touts FDA manage

.Our team presently know that Takeda is actually intending to find a road to the FDA for epilepsy me...

VBI Vaccinations declare bankruptcy, finds asset purchase

.Immunology biotech VBI Vaccines is drifting dangerously close to the climax, with plans to file for...

Celldex anti-cKIT antitoxin lower hives in yet another stage 2 study

.It is actually hard to muscle mass in on a room as affordable as immunology, however Celldex Therap...

Boehringer offers up to $1.3 B for checkpoint inhibitor biotech

.Boehringer Ingelheim is actually offering up to $1.3 billion for Nerio Rehabs as well as a preclini...

Ventyx's last hope for inflammatory med sides in Crohn's failing

.Ventyx Biosciences' Crohn's disease medication performed certainly not assist clients attain remiss...

Cognition's stage 2 SHINE data stain Alzheimer's prospect

.Cognition Therapies' stage 2 luster test has taken several of the luster off the Alzheimer's condit...

BMS axes bispecific months after filing to run phase 3 test

.Bristol Myers Squibb has had a whiplash change of heart on its own BCMA bispecific T-cell engager, ...

Charles Baum takes over Terremoto as CEO

.Charles Baum, M.D., Ph.D., who oversaw Mirati Rehabs' $ 5.8 billion purchase to Bristol Myers Squib...

Asarina to shut after initiatives to partner Tourette's medicine stop working

.After connecting to much more than 200 providers to partner a Tourette disorder therapy that presen...